Ascend Wellness Holdings (AAWH) Change in Receivables (2020 - 2026)
Ascend Wellness Holdings (AAWH) posted quarterly Change in Receivables of -$601000.0 for Q1 2026, down 437.64% year-over-year from $178000.0 in Q1 2025, and up 67.01% quarter-over-quarter from -$1.8 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Change in Receivables (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Change in Receivables history runs 7 years deep, the most recent figure standing at -$601000.0 for Q1 2026.
- In Q1 2026, Change in Receivables fell 437.64% year-over-year to -$601000.0; the TTM figure through Mar 2026 stood at -$8.7 million (down 1158.27% YoY), while the FY2025 annual figure was -$7.9 million, down 196.07% from the prior year.
- Change in Receivables for Q1 2026 stood at -$601000.0, up from -$1.8 million in the prior quarter.
- The five-year high for Change in Receivables was $7.6 million in Q1 2024, with the low at -$6.1 million in Q2 2025.
- The 5-year median for Change in Receivables is $714000.0 (2022), against an average of $1.2 million.
- The sharpest annual moves came in 2023 and 2025: Change in Receivables jumped 320.5% in 2023, then slumped 940.17% in 2025.
- Ascend Wellness Holdings' Change in Receivables stood at $714000.0 in 2022, then soared by 308.82% to $2.9 million in 2023, then plunged by 176.5% to -$2.2 million in 2024, then grew by 18.41% to -$1.8 million in 2025, then surged by 67.01% to -$601000.0 in 2026.
- Business Quant data shows AAWH's Change in Receivables at -$601000.0 in Q1 2026, -$1.8 million in Q4 2025, and -$191000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 91.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -445.26 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | -1.70 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 126.50 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 84.30 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Ascend Wellness Holdings | 97.42 Mn | 30.42 Mn | 45.49 Mn | -162,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -162,000.00 |
| Jun 30, 2026 | -162,000.00 |
| Mar 31, 2026 | -601,000.00 |
| Mar 31, 2026 | -601,000.00 |
| Dec 31, 2025 | -1.82 Mn |
| Dec 31, 2025 | -1.82 Mn |
| Sep 30, 2025 | -191,000.00 |
| Sep 30, 2025 | -191,000.00 |
| Jun 30, 2025 | -6.09 Mn |
| Jun 30, 2025 | -6.09 Mn |
| Mar 31, 2025 | 178,000.00 |
| Mar 31, 2025 | 178,000.00 |
| Dec 31, 2024 | -2.23 Mn |
| Dec 31, 2024 | -2.23 Mn |
| Sep 30, 2024 | 3.46 Mn |
| Sep 30, 2024 | 3.46 Mn |
| Jun 30, 2024 | -585,000.00 |
| Jun 30, 2024 | -585,000.00 |
| Mar 31, 2024 | 7.60 Mn |
| Mar 31, 2024 | 7.60 Mn |